Maravai brands set the standard in nucleic acid products and services, enzyme development, and biologics safety testing. From producing revolutionary mRNA technologies that drive infectious disease vaccines, cancer vaccines, and other cell and gene therapies to delivering gold-standard bioprocess impurity detection solutions, Maravai is helping life sciences companies overcome their biggest development and manufacturing challenges to streamline and scale from research through clinical trials to commercialization.
For over 35 years, Maravai’s brands have served as proven catalysts for innovative, lifesaving technology for humanity. Across our portfolio of brands, we hold numerous patents and offer more than 1,500 innovative products and services, including CleanCap® technology, CleanAmp® hot start PCR, Antibody Affinity Extraction™, EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV®, Sterling™, Glen Pak™, Glen Gel-Pak™.
Each of our brands are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications.
-
Industry
-
Biotechnology Research
-
Company size
-
501-1,000 employees
-
Headquarters
-
San Diego, California
-
Type
-
Public Company
-
Founded
-
2014
-
Specialties
-
mRNA, CDMO Services, Impurity Detection Assays, Molecular Diagnostic Tools, Nucleic Acid Production, Life Sciences, Biotechnology, Nucleotide Synthesis, Oligonucleotides, DNA, RNA, Genomics, Gene Therapy, Bioprocess Impurity Detection, Host Cell Protein Experts, mRNA Experts, Molecular Biology, Enzymes, Custom Chemistry, and Nucleic Acid Therapies